Evaluation of Different Patterns of Drug Consumption in the Ranking of Race Horses in National Racing of Iran: A Retrospective Study 2002-2015

Main Article Content

Meysam Tehrani-Sharif
Amir Zakian


Introduction: Doping is fraudulent and must be prevented in the interests of horse racing as a national recreation. No sport can survive without the confidence of its supporters, so all deceitful practices must be eliminated. This study aimed to determine the rate of drug consumption in horse races in Iran during 2002, 2003, and 2005-2015 and evaluate Iran’s current dope control management.

Materials and methods: The winner’s method was used to choose horses for drug testing, and only the first and second-place finishers in each race, and seldom the third, were picked. Data of horses during 13 years (2002, 2003, and 2005-2015) were collected. The dope test documents of 2004 were incomplete, so the related data were not analyzed.

Results: The mean dope rate (2002, 2003, and 2005-2015) was 15.83%. The dope rates of 2002, 2003, and 2005-2015 were 29.4%, 33.8%, 21.7%, 10.54 %, 11.14%, 11.47%, 8.62%,4.71%, 18.6%, 20.6%, 16.9%, 22.6%, and 6.72 % respectively. From 2003 to 2010, the drug rate progressively decreased from 33.8% to 4.71%. Morphine, Phenylbutazone, Oxyphenbutazone, and caffeine were the most often utilized medicines. Twenty-one drug family types based on the mode of action were used through the years, of which 23.07 percent were combinations. From 2002 to 2010, the variety of medications utilized progressively declined. The noticeable aspect was high prevalence of dope in Iran, compared to developed countries.

Conclusion: The results showed that the dope rate reduced from 2002 to 2015 in Iran racehorses. Routine tests are suggested for controlling doping, and strict rules must be established to prevent doping.

Article Details

How to Cite
Tehrani-Sharif, M., & Zakian, A. (2022). Evaluation of Different Patterns of Drug Consumption in the Ranking of Race Horses in National Racing of Iran: A Retrospective Study 2002-2015. Farm Animal Health and Nutrition, 1(2), 39–45. https://doi.org/10.58803/fahn.v1i2.11
Original Articles


Stevenson A, editor. Oxford Dictionary of English. Oxford UniversityPress, USA; 2010 Aug 19.

Toutain PL. Veterinary medicines and competition animals: The question of medication versus doping control. In: Cunningham F,

Elliott J, Lees P, editors. Comparative and Veterinary Pharmacology. Handbook of Experimental Pharmacology, vol 199. Berlin, Heidelberg:Springer; 2010. p. 315-339. DOI: https://doi.org/10.1007/978-3-642-10324-7_13

Fédération equestre internationale (FEI) [International Equestrian Federation]. Available at: www.horsesport.org

World anti-doping agency (WADA). Available at: https://www.wada-ama.org/en/%20accessed%20in%2001/01/2008

Fragkaki AG, Kioukia-Fougia N, Kiousi P, Kioussi M, and Tsivou M. Challenges in detecting substances for equine anti-doping. Drug Test

Anal. 2017; 9(9): 1291-1303. DOI: https://doi.org/10.1002/dta.2162

Higgins AJ. PL04 from ancient Greece to modern Athens: 3000 years of doping in competition horses. J vet Pharmacol Therap. 2006; 29(1): 1-10.

Wong ASY, Leung GNW, Leung DKK, and Wan TSM. Doping control analysis of anabolic steroids in equine urine by gas chromatography tandem mass spectrometry. Drug Test Anal. 2017; 9(9): 1320-1327. DOI: https://doi.org/10.1002/dta.2090

Tou K, Cawley A, Bowen C, Sornalingam K, and Fu S. Measurements of hydrocortisone and cortisone for longitudinal profiling of equine

Lotfollahzadeh S, Mokhber-Dezfouli MR, Tajik P, Bokaie S, and Watson DG. A survey on two years of medication regulation in horse races in Iran. Equine Vet J. 2010; 42(2): 161-163. DOI: https://doi.org/10.2746/042516409X471449

Zakian A, Sharif M, Shahrani H, Gholami N, Rezaeian H, and Elikaei V. Doping with strychnine in Turkomen stallion race-horse in Iran: A case report. Der Pharm. Lett. 2015; 7(6): 110-115. Available at: https://www.cabdirect.org/cabdirect/abstract/20153270948

Prohibited substances. International Federation of horseracing authorities, Boulogne; 2009. p. 20-23. Available at: https://www.ifhaonline.org/resources/prohibited_substances_2009. pdf

Knych HK, Stanley SD, Harrison LM, and Mckemie DS. Pharmacokinetics of betamethasone in plasma, urine, and synovial fluid following intra-articular administration to exercised

thoroughbred horses. Drug Test Anal. 2017; 9(9): 1385-1391. DOI: https://doi.org/10.1002/dta.2170

Keen B, Cawley A, Reedy B, and Fu S. Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues. Drug Test Anal. 2022; 14(5): 794-807. DOI: https://doi.org/10.1002/dta.3245

Dahlgren AR, Knych HK, Arthur RM, Durbin-Johnson BP, and Finno CJ. Transcriptomic markers of recombinant human erythropoietin micro- dosing in thoroughbred horses. Genes. 2021; 12(12): 1874. DOI: https://doi.org/10.3390/genes12121874

Bravo-Veyrat S, and Hopfgartner G. Mass specspectrometry-basedh- throughput bioanalysis of low molecular weight compounds: Are we ready to support personalized medicine?. Anal Bioanal Chem. 2022; 414(1): 181-192. DOI: https://doi.org/10.1007/s00216-021-03583-2

Budhraja A, Camargo AF, Hughes C, Lehner AF, Stirling K, Bernna N, et al. Caffeine and theobromine identifications in post-race urines: Threshold levels and regulatory significance of such identifications. AAEP Proc. 2007; 53: 87-92. Available at: https://b2n.ir/d46511